Background: Diabetic ketoacidosis (DKA) is a serious acute complication of both type 1 and type 2 diabetes that requires prompt management. Limited data exist supporting the use of a 2-bag DKA protocol in adult patients across all levels of care.
Objective: To evaluate the efficacy and safety of a 2-bag DKA protocol in comparison with a traditional DKA management strategy.
Methods: Retrospective review of patients admitted with DKA between January 1, 2021, and February 28, 2022, at a single center. Patients were separated into 2 cohorts, traditional or 2-bag. The primary outcome was time to anion gap closure and/or beta-hydroxybutyrate normalization. Secondary outcomes include length of hospitalization, insulin infusion time, and hypoglycemic events.
Results: One hundred forty-three patients had a DKA order set initiated during their admission, 59 in the traditional cohort and 84 in the 2-bag cohort. Mean time to anion gap closure was shorter in the 2-bag cohort (12.7 vs 16.9 hours; = 0.005) and beta-hydroxybutyrate normalization (15.6 vs 25.6 hours; = 0.026). No difference in hospital length of stay (4 vs 6 days; = 0.113), duration of insulin infusion (41.6 vs 40.6 hours; = 0.455), or rates of hypoglycemia (6 vs 4; = 0.872) was seen.
Conclusion And Relevance: Implementation of a 2-bag DKA protocol in the inpatient setting was associated with a shorter time to anion gap closure and beta-hydroxybutyrate normalization. These findings support the option of expansion of a 2-bag DKA protocol to adult patients across all levels of care irrespective of the admission diagnosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/10600280231163838 | DOI Listing |
J Pharm Pract
February 2025
Michigan Medicine, Ann Arbor, MI, USA.
Ann Pharmacother
December 2023
Department of Pharmacy, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Background: Diabetic ketoacidosis (DKA) is a serious acute complication of both type 1 and type 2 diabetes that requires prompt management. Limited data exist supporting the use of a 2-bag DKA protocol in adult patients across all levels of care.
Objective: To evaluate the efficacy and safety of a 2-bag DKA protocol in comparison with a traditional DKA management strategy.
J Pediatr Pharmacol Ther
January 2016
Arnold Palmer Hospital for Children, Orlando, Florida.
Diabetic ketoacidosis (DKA) is a leading cause of morbidity and mortality in children with type 1 diabetes. We implemented a standardized DKA management protocol by using a 2-bag intravenous (IV) fluid system. The purpose of the study was to examine if the protocol improved clinical outcomes and process efficiency.
View Article and Find Full Text PDFJ Pediatr
June 2009
Pediatric Intensive Care Unit, Children's Hospital La Fe, Valencia, Spain.
Objectives: To analyze in a retrospective cohort if sodium concentration in the rehydration fluids influence natremia in children with diabetic ketoacidosis (DKA).
Study Design: Consecutive episodes of diabetic ketoacidosis admitted in a tertiary care referral center from 2000 to 2005. Rehydration was programmed for 48 hours with a 2-bag system.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!